Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
Meng-Wei Xiao, Shixin Lin, Zhaohua Shen, et al.
Gastroenterology Research and Practice (2019) Vol. 2019, pp. 1-19
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Jiezhong Chen, Luis Vitetta
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5214-5214
Open Access | Times Cited: 232
Human microbiome and metabolic health: An overview of systematic reviews
Nathalie Michels, Semi Zouiouich, Bert Vanderbauwhede, et al.
Obesity Reviews (2022) Vol. 23, Iss. 4
Open Access | Times Cited: 80
Promises of microbiome-based therapies
Jasmohan S. Bajaj, Siew C. Ng, Bernd Schnabl
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1379-1391
Open Access | Times Cited: 71
Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
Marta Maestri, Francesco Santopaolo, Maurizio Pompili, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 44
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 15
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
Anne Fougerat, Alexandra Montagner, Nicolas Loiseau, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1638-1638
Open Access | Times Cited: 112
Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis
Vali Musazadeh, Neda Roshanravan, Parvin Dehghan, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 39
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, et al.
Clinical Nutrition (2022) Vol. 41, Iss. 10, pp. 2364-2405
Open Access | Times Cited: 38
Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
M.J.M. de Koning, Hilde Herrema, Max Nieuwdorp, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review
Azin Vakilpour, Ehsan Amini‐Salehi, Arman Soltani Moghadam, et al.
Nutrition and Diabetes (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Can modulation of gut microbiota affect anthropometric indices in patients with non-alcoholic fatty liver disease? An umbrella meta-analysis of randomized controlled trials
Ehsan Amini‐Salehi, Sandeep Samethadka Nayak, Gautam Maddineni, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 5, pp. 2900-2910
Open Access | Times Cited: 7
Beneficial Effects of Lactobacillus plantarum Strains on Non-Alcoholic Fatty Liver Disease in High Fat/High Fructose Diet-Fed Rats
Eun‐Jung Park, You‐Suk Lee, Sung Min Kim, et al.
Nutrients (2020) Vol. 12, Iss. 2, pp. 542-542
Open Access | Times Cited: 50
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, et al.
United European Gastroenterology Journal (2022) Vol. 10, Iss. 7, pp. 663-720
Open Access | Times Cited: 36
Probiotic therapy, a novel and efficient adjuvant approach to improve glycemic status: An umbrella meta-analysis
Meysam Zarezadeh, Vali Musazadeh, Amir Hossein Faghfouri, et al.
Pharmacological Research (2022) Vol. 183, pp. 106397-106397
Closed Access | Times Cited: 29
Synbiotic formulations with microbial biofilm, animal derived (casein, collagen, chitosan) and plant derived (starch, cellulose, alginate) prebiotic polymers: A review
Juhi Chauhan, Rakesh Kumar Sharma
International Journal of Biological Macromolecules (2023) Vol. 248, pp. 125873-125873
Closed Access | Times Cited: 18
Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study
Amirhossein Naghipour, Ehsan Amini‐Salehi, Mahdi Orang Gorabzarmakhi, et al.
Systematic Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Effect of a Probiotic and a Synbiotic on Body Fat Mass, Body Weight and Traits of Metabolic Syndrome in Individuals with Abdominal Overweight: A Human, Double-Blind, Randomised, Controlled Clinical Study
Christiane Laue, E. Papazova, Angelika Pannenbeckers, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 3039-3039
Open Access | Times Cited: 17
The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis
Ehsan Amini‐Salehi, Soheil Hassanipour, Mohammad‐Hossein Keivanlou, et al.
Nutrition Reviews (2023) Vol. 82, Iss. 6, pp. 815-830
Closed Access | Times Cited: 17
The effects of prebiotic, probiotic or synbiotic supplementation on overweight/obesity indicators: an umbrella review of the trials’ meta-analyses
Niloufar Rasaei, Mohammadreza Heidari, Fataneh Esmaeili, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 7
An umbrella review of meta-analyses on the effects of microbial therapy in metabolic dysfunction-associated steatotic liver disease
Yuanyue Yao, Qing Hong, Siqi Ding, et al.
Clinical Nutrition (2025) Vol. 47, pp. 1-13
Closed Access
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
Jin Zhou, Madhulika Tripathi, Rohit A. Sinha, et al.
Hepatoma Research (2021) Vol. 2021
Open Access | Times Cited: 38
Probiotics act as a potent intervention in improving lipid profile: An umbrella systematic review and meta-analysis
Meysam Zarezadeh, Vali Musazadeh, Amir Hossein Faghfouri, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 2, pp. 145-158
Closed Access | Times Cited: 37
Anti-obesity properties of probiotics; a considerable medical nutrition intervention: Findings from an umbrella meta-analysis
Vali Musazadeh, Meysam Zarezadeh, Faezeh Ghalichi, et al.
European Journal of Pharmacology (2022) Vol. 928, pp. 175069-175069
Closed Access | Times Cited: 23
The effect of probiotic and synbiotic supplementation on lipid parameters among patients with cardiometabolic risk factors: a systematic review and meta-analysis of clinical trials
Zeinab Ghorbani, Asma Kazemi, Theda Ulrike Patricia Bartolomaeus, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 4, pp. 933-956
Closed Access | Times Cited: 23
Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses
Abinash Mahapatro, Fnu Bawna, Vikash Kumar, et al.
Clinical Nutrition ESPEN (2023) Vol. 57, pp. 475-486
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top